Peptides

Showing 25–36 of 51 results

• 
  API

  Motixafortide

  CAS:664334-36-5

  Status:R&D

  Indications:Endocrine, nutritional and metabolic diseases
• 
  API

  Nesiritide

  CAS:114471-18-0

  Status:DMF

  Indications:Diseases of the circulatory system
• 
  API

  Octreotide

  CAS:83150-76-9

  Status:CEP, NMPA, WC

  Indications:Neoplasms and Endocrine, Nutritional and Metabolic Diseases
• 
  API

  Oral Semaglutide ablet Intermediate Granules

• 
  API

  Oxytocin

  CAS:50-56-6

  Status:DMF, CEP, NMPA, WC

  Indications:Pregnancy, childbirth, and puerperium
• 
  API

  Palopegteriparatide

  CAS:2222514-07-8

  Status:R&D

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Pegcetacoplan

  CAS:2019171-69-6

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  API

  Plecanatide

  CAS:467426-54-6
  Status:Validation Completed, DMF (2025)
  Indications:Diseases of the digestive system

• 
  API

  Protirelin

• 
  API

  Retatrutide

  CAS:2381089-83-2

  Status:R&D

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Rusfertide

  CAS:1628323-80-7

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  API

  Semaglutide (Chemical synthesis)

  CAS:910463-68-2

  Status:DMF, WC

  Indications:Endocrine, nutritional, and metabolic disease